STTK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STTK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Shattuck Labs's net issuance of debt for the three months ended in Sep. 2024 was $0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.
The historical data trend for Shattuck Labs's Net Issuance of Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shattuck Labs Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Net Issuance of Debt | Get a 7-Day Free Trial | - | - | - | - | - |
Shattuck Labs Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Net Issuance of Debt | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Shattuck Labs's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Redmile Group, Llc | director, 10 percent owner | ONE LETTERMAN DRIVE, BUILDING D, SUITE D3-300, SAN FRANCISCO CA 94129 |
Taylor Schreiber | director, officer: Chief Executive Officer | 100 EUROPA DRIVE, CHAPEL HILL NC 27517 |
Tyler Brous | director | 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703 |
Stephen Stout | officer: See Remarks | C/O SHATTUCK LABS, INC., 500 W. 5TH STREET, SUITE 1200, AUSTIN TX 78701 |
Andrew R Neill | officer: See Remarks | 1018 W 11TH STREET, SUITE 100, AUSTIN TX 78703 |
George Golumbeski | director | C/O CELGENE CORP., 86 MORRIS AVENUE, SUMMIT NJ 07901 |
Abhinav A. Shukla | officer: Chief Technical Officer | 500 W. 5TH STREET, SUITE 1200, AUSTIN TX 78701 |
Carrie Brownstein | director | 500 W. 5TH ST., SUITE 1200, AUSTIN TX 78701 |
Erin Ator Thomson | officer: General Counsel | 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703 |
Josiah Hornblower | director, 10 percent owner, officer: Chairman | 3317 BOWMAN AVE, AUSTIN TX 78703 |
Neil W Gibson | director | C/O REGULUS THERAPEUTICS INC., 3545 JOHN HOPKINS COURT SUITE 210, SAN DIEGO CA 92121 |
Helen M Boudreau | director | 200 TECHNOLOGY SQUARE, 4TH FLOOR, CAMBRIDGE MA 02139 |
Arundathy N. Pandite | officer: Chief Medical Officer | 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703 |
Victor Stone | director | 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703 |
Casi Deyoung | officer: Chief Business Officer | C/O MIRNA THERAPEUTICS, INC., 2150 WOODWARD ST., SUITE 100, AUSTIN TX 78744 |
From GuruFocus
By Marketwired • 07-01-2024
By Marketwired • 10-15-2024
By Marketwired • 10-01-2024
By PRNewswire • 10-25-2024
By Business Wire • 10-29-2024
By PRNewswire • 02-14-2024
By PRNewswire • 10-16-2024
By Business Wire • 10-28-2024
By Marketwired • 08-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.